Approval · Notice of Compliance 496 · 2002
FLUVOXAMINE TABLETS: Notice of Compliance 496
Issued November 28, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 496
- Date
- November 28, 2002
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antidepressant, antiobsessional agent
- Canadian reference product
- LUVOX (Solvay Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUVOXAMINE TABLETS | 02246822 | Cancelled Pre Market |
| FLUVOXAMINE TABLETS | 02246823 | Cancelled Pre Market |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB